SYNTHETIC MHC CLASS I PEPTIDE PROLONGS CARDIAC SURVIVAL AND ATTENUATES TRANSPLANT ARTERIOSCLEROSIS IN THE LEWIS???FISCHER 344 MODEL OF CHRONIC ALLOGRAFT REJECTION
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Transplantation
Reference26 articles.
1. Chronic transplant rejection
2. CHRONIC VASCULAR REJECTION OF THE HEART AND THE KIDNEY—HAVE RATIONAL TREATMENT OPTIONS EMERGED?
3. Chronic renal transplant loss
4. Chronic Rejection in Experimental Cardiac Transplantation: Studies in the Lewis-F344 Model
Cited by 27 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Cross-Reactive Donor-Specific CD8+ Tregs Efficiently Prevent Transplant Rejection;Cell Reports;2019-12
2. Small Animal Models of Transplantation;Textbook of Organ Transplantation;2014-07-25
3. MHC-derived allopeptide activates TCR-biased CD8+ Tregs and suppresses organ rejection;Journal of Clinical Investigation;2014-05-01
4. Prediction of peptides binding to MHC class I and II alleles by temporal motif mining;BMC Bioinformatics;2013-01
5. Soluble donor-like MHC class I proteins induce CD4+CD25+CD8−FoxP3+ cells with potential to ameliorate graft chronic injury;Transplant Immunology;2011-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3